Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.
about
How citation distortions create unfounded authority: analysis of a citation networkCaenorhabditis elegans as a model organism to study APP functionThe ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositisTargeting protein homeostasis in sporadic inclusion body myositis.Autophagy in the Pathogenesis of DiseaseIntracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification.Endothelial and myogenic differentiation of hematopoietic progenitor cells in inflammatory myopathies.Immune and myodegenerative pathomechanisms in inclusion body myositisGender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stressAberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositisEffects of nonsteroidal anti-inflammatory drugs on amyloid-beta pathology in mouse skeletal muscle.Theories of the pathogenesis of inclusion body myositis.Calpain inhibition attenuates intracellular changes in muscle cells in response to extracellular inflammatory stimulation.Proteomic study of sporadic inclusion body myositis.The protein oxidation repair enzyme methionine sulfoxide reductase a modulates Aβ aggregation and toxicity in vivo.Endoplasmic reticulum stress induces myostatin precursor protein and NF-kappaB in cultured human muscle fibers: relevance to inclusion body myositis.AbetaPP-overexpression and proteasome inhibition increase alphaB-crystallin in cultured human muscle: relevance to inclusion-body myositis.Oxidative stress, Nrf2 and keratin up-regulation associate with Mallory-Denk body formation in mouse erythropoietic protoporphyriaCorruption and spread of pathogenic proteins in neurodegenerative diseases.Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositisInterrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscleMolecular events linking cholesterol to Alzheimer's disease and inclusion body myositis in a rabbit model.Limb-girdle muscular dystrophy 1F is caused by a microdeletion in the transportin 3 gene.Autophagy - An Emerging Anti-Aging Mechanism.Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains.Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.The expanding realm of prion phenomena in neurodegenerative disease.Mitochondrial dysfunction in myofibrillar myopathy.Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.Prion-like mechanisms in neurodegenerative diseases.Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkersPathogenesis, classification and treatment of inflammatory myopathies.Expression and function of APP and its metabolites outside the central nervous system.From soluble aβ to progressive aβ aggregation: could prion-like templated misfolding play a role?Dysfunction in protein clearance by the proteasome: impact on autoinflammatory diseases.Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer's disease.Transforming growth factor-β signaling is upregulated in sporadic inclusion body myositis.TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia.Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscle.APP(DeltaNL695) expression in murine tissue downregulates CNBP expression.
P2860
Q24260685-EF124B71-9CA8-4176-93F6-1A17D274C9D7Q26851244-2617D9DF-1917-4BC2-9CB0-7A8945A9C67CQ27301955-187CECC0-46F0-44C9-ABF1-D89633352EF9Q27324564-4A972B64-2A37-4E9E-B513-FDD7FF7DFE2EQ27860558-50A033B5-EA93-4846-B782-0E1A34E6FF87Q30485664-59553298-F6CD-4C0F-B0C8-8E9C2BF5D63AQ33348491-31530341-8180-402A-9717-9011688B4AB3Q33753870-0DF31B82-7631-4F3A-A4F8-2809A9917575Q33759524-12299FFE-7E16-463F-B524-9F762E6650A5Q33784450-19F7099E-CE1A-414E-82C3-CB51A7DEA340Q34020429-83487CEE-3C1C-4C2F-B229-DFBA769FCCACQ34090910-1591CD81-EFF2-4BE6-9C65-0234490241B5Q34175815-3A7C63B5-47F3-4E04-BFF0-E5D28E879F68Q34234305-5B5743C4-AADB-4703-93AC-3BF58982B42CQ34729853-DBF8E91A-90A0-4F19-8696-DDEB6465D396Q35873911-51FD3D05-0F60-49E5-9773-21297EC328BCQ35990823-6E12F121-7AE1-42C2-8142-4955A3FCE052Q36075749-4DB5A9DF-73AB-4941-A27C-3C9D73FE3B82Q36286068-D80FB9E7-D63A-472C-AD35-B3D927710F5AQ36609374-99261A46-F25E-427F-8A18-EA6274C92055Q36633131-7557E09E-68F3-4535-B54E-11DB8D283654Q36678662-7BD86E8F-6012-406F-A036-EBDAF92EB79CQ36789599-66A38F2E-79D3-4D60-838C-3D6FA8DCEA1BQ36908386-E35853C9-CF8E-4DF2-A5B9-5C30F2C2FCF9Q37083992-17FB74AB-53BD-4A67-9505-C73ABB81B938Q37201405-8498C470-5F60-42CA-B8A9-EECFB7717F21Q37266705-732047B8-84EF-4CB9-B5E3-7D450AE912B7Q37343276-4C1443E9-221E-49E4-B063-71C13B7A1208Q37452177-01EEAB6B-BD8E-4EF9-905E-03A273184315Q37661351-101080D2-0C8D-4C58-9491-172EF7C49F91Q37776127-72A5F94C-ACB7-410F-AF6B-1596D2969A85Q37862083-CD6670AC-0890-43C5-A1BD-18D8E417C94FQ38030678-7C1A095B-CBE8-4CC2-82DA-2947B7FE24F3Q38099070-3A9959D9-732F-425B-9F15-B7380E6BB68EQ38473815-3396AFAF-072B-4F64-A8FB-BB86B2CF034CQ39005823-0C66F896-858C-4F06-B8A8-A5CF8671C627Q39395489-C5AEB54C-F338-404C-B4DC-655A452F27B7Q41667459-875627E0-1E34-4231-9220-CF18F9D6513AQ41867781-FB4060B8-51E9-4FAC-A106-1205E97AE768Q42534464-ACFC76B5-0887-4C53-8452-0253BF6BFB6F
P2860
Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Inclusion-body myositis: a myo ...... ng, and proteasome inhibition.
@ast
Inclusion-body myositis: a myo ...... ng, and proteasome inhibition.
@en
Inclusion-body myositis: a myo ...... ng, and proteasome inhibition.
@nl
type
label
Inclusion-body myositis: a myo ...... ng, and proteasome inhibition.
@ast
Inclusion-body myositis: a myo ...... ng, and proteasome inhibition.
@en
Inclusion-body myositis: a myo ...... ng, and proteasome inhibition.
@nl
prefLabel
Inclusion-body myositis: a myo ...... ng, and proteasome inhibition.
@ast
Inclusion-body myositis: a myo ...... ng, and proteasome inhibition.
@en
Inclusion-body myositis: a myo ...... ng, and proteasome inhibition.
@nl
P1433
P1476
Inclusion-body myositis: a myo ...... ng, and proteasome inhibition.
@en
P2093
Valerie Askanas
W King Engel
P304
P356
10.1212/01.WNL.0000192128.13875.1E
P407
P433
P577
2006-01-01T00:00:00Z